Patents Assigned to Protia, LLC
  • ALCOHOLIC COMPOSITIONS HAVING A LOWERED RISK OF ACETALDEHYDEMIA
    Publication number: 20150011651
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: January 13, 2014
    Publication date: January 8, 2015
    Applicant: PROTIA, LLC
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • DEUTERIUM-ENRICHED RUBOXISTAURIN
    Publication number: 20120136037
    Abstract: The present application describes deuterium-enriched ruboxistaurin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 3, 2008
    Publication date: May 31, 2012
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MEROPENEM
    Publication number: 20120122833
    Abstract: The present application describes deuterium-enriched meropenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: May 17, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SAXAGLIPTIN
    Publication number: 20120035261
    Abstract: The present application describes deuterium-enriched saxagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 3, 2011
    Publication date: February 9, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED IXABEPILONE
    Publication number: 20120035227
    Abstract: The present application describes deuterium-enriched ixabepilone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 3, 2011
    Publication date: February 9, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DASATINIB
    Publication number: 20120015956
    Abstract: The present application describes deuterium-enriched dasatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: December 9, 2010
    Publication date: January 19, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ALOGLIPTIN
    Publication number: 20110312983
    Abstract: The present application describes deuterium-enriched alogliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: December 9, 2010
    Publication date: December 22, 2011
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DORIPENEM
    Publication number: 20110281927
    Abstract: The present application describes deuterium-enriched doripenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 17, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TOLTERODINE
    Publication number: 20110281952
    Abstract: The present application describes deuterium-enriched tolterodine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 17, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RISPERIDONE
    Publication number: 20110212976
    Abstract: The present application describes deuterium-enriched risperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: July 5, 2010
    Publication date: September 1, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DAPOXETINE
    Publication number: 20110201690
    Abstract: The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 18, 2010
    Publication date: August 18, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SDX-101
    Publication number: 20110160270
    Abstract: The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: March 7, 2011
    Publication date: June 30, 2011
    Applicant: PROTIA, LLC.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ODANSETRON
    Publication number: 20110144174
    Abstract: The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 16, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED BUPROPION
    Publication number: 20110130463
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: May 19, 2010
    Publication date: June 2, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ATORVASTATIN
    Publication number: 20110124704
    Abstract: The present application describes deuterium-enriched atorvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: May 18, 2010
    Publication date: May 26, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DISUFENTON
    Publication number: 20110124732
    Abstract: The present application describes deuterium-enriched disufenton, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: May 19, 2010
    Publication date: May 26, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SALMETEROL
    Publication number: 20110118358
    Abstract: The present application describes deuterium-enriched salmeterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: May 19, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched ondansetron
    Patent number: 7919516
    Abstract: The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: April 5, 2011
    Assignee: Protia, LLC
    Inventor: Anthony W Czarnik
  • Deuterium-enriched oseltamivir
    Patent number: 7915309
    Abstract: The present application describes deuterium-enriched oseltamivir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: March 29, 2011
    Assignee: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED NELARABINE
    Publication number: 20110046082
    Abstract: The present application describes deuterium-enriched nelarabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik